Brief: Tscan Therapeutics Reports First Quarter 2022 Financial Results
09/05/2022 12:23
May 9 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND UPCOMING ANTICIPATED MILESTONES
* Q1 REVENUE $3.0 MILLION
* ENDED Q1 WITH CASH AND CASH EQUIVALENTS OF $140.8 MILLION,
FUNDING OPERATIONS INTO 2024
* QTRLY LOSS PER SHARE $0.67
* Q1 EARNINGS PER SHARE VIEW $-0.73 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7MV40T
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing